| CATALYST PHARMACEUTICAL |
| USA |
| Gesundheit |
| US14888U1016 / A0LCUL |
| CN2 (Frankfurt) / CPRX (NASDAQ) |
| FRA:CN2, ETR:CN2, CN2:GR, NASDAQ:CPRX |
| - |
| https://catalystpharma.co.. |
|
Catalyst Pharmaceuticals Inc. is a biopharmaceutic..
>Volltext.. |
| 2272.16 Mio. EUR |
| 1721.73 Mio. EUR |
| 484.96 Mio. EUR |
| 244.33 Mio. EUR |
| 181.19 Mio. EUR |
| 1.5 EUR |
| 2.6 Mio. EUR |
| 566.84 Mio. EUR |
| 238.87 Mio. EUR |
| 5.78 |
| 16.88% |
| 178.41% |
| - |
| - |
| - |
| - |
| CATALYST PHARMACEUTICAL, CATALYST PHARMACEUTICALS, CATALYST PHARMA |
| 06.11.25 |